1 |
FP86 |
Comparison of intravitreal ranibicizumab+triamcinolone Vs monotherapy in treatment naiive DME & RVO |
DR. RESHMA PADMARAM NAIR |
DR. RESHMA PADMARAM NAIR |
2 |
FP90 |
Correlation of serum homocysteine level with DM, DR and DME ā a hospital-based study |
DR. RUBBLE MANGLA |
DR. RUBBLE MANGLA |
3 |
FP110 |
Onion ring sign on spectral domain OCT in diabetic macular edema: its evolution and outcomes |
Dr. RAMESH VENKATESH |
Dr. RAMESH VENKATESH |
4 |
FP201 |
Relevance of flat irregular pigment epithelial detachment |
DR. ANUJA PATIL |
DR. ANUJA PATIL |
5 |
FP246 |
RECALCITRANT DME- THE ROAD AHEAD |
DR. RAHUL CHOUBEY |
DR. RAHUL CHOUBEY |
6 |
FP348 |
Retro Mode ā Does it provide Newer insight into Dry Age Related Macular Degeneration(AMD) |
DR. ANJU BANSAL |
DR. ANJU BANSAL |
7 |
FP777 |
Functional and morphological changes in eyes with CNVM switched to intravitreal Brolucizumab |
Dr. Ashapurna Borgohain |
Dr. Ashapurna Borgohain |
8 |
FP976 |
A STUDY ON THE PHENOTYPIC VARIATIONS OF ENHANCED āSā CONE SYNDROME IN INDIAN POPULATION |
Dr. SHERINA THOMAS |
Dr. SHERINA THOMAS |
9 |
FP1043 |
FLAT IRREGULAR PED IN CHRONIC AND RECURRENT CENTRAL SEROUS CHORIORETINOPATHY- OUR EXPERIENCE |
DR. SURABHI SANE |
DR. SURABHI SANE |
10 |
FP1139 |
Correlation of OCT biomarker PROS & CMT in Diabetic Macular Oedema : a Tertiary care Hospital study |
DR. AYUSHI SARDANA |
DR. AYUSHI SARDANA |
11 |
FP1362 |
Clinical And Biochemical Characteristics of Patients with Vascular Occlusions In
Post COVID 19 ROCM |
DR SHIVANI SINHA |
DR SHIVANI SINHA |
12 |
FP1479 |
Coats Disease in India: Clinical Features, Treatment and Outcomes in Patients Older than Fifty Years |
DR. SAARANG HANSRAJ |
DR. SAARANG HANSRAJ |
13 |
FP1671 |
Generation of RPE from hiPSC, subretinal transplantation in rats & preparations for clinical trials |
DR. RAJANI R. BATTU |
DR. RAJANI R. BATTU |
14 |
FP1866 |
Micromorphometric prognostic factors on OCT in Epidemic retinitis( ER) |
Dr. APOORVA A.G. |
Mrs.DR. MEGHANA NEERALAGI |
15 |
FP1871 |
OCTA analysis of foveal avascular zone and vessel density in eyes treated with Anti-VEGF for DME |
DR. KIRTIKA JAIN |
DR. KIRTIKA JAIN |
16 |
FP1907 |
Milder than type 1 Retinopathy of prematurity: disease profile and indications of treatment |
Dr.NEHA KHURANA |
Dr.NEHA KHURANA |
17 |
FP1952 |
Novel molecule mediated inhibition of ICAM as target for diabetic vascular leakage:Preclinical trial |
DR. THIRUMALESH M. B. |
DR. THIRUMALESH M. B. |
18 |
FP2001 |
Misadventures with intravitreal triamcinolone acetonide- A case series |
Dr. AMRITA VERMA |
Dr. AMRITA VERMA |
19 |
FP2030 |
OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN CENTRAL SEROUS CHORIO-RETINOPATHY AFTER EPLERENONE |
Dr. PUNITA KUMARI SODHI |
Dr. PUNITA KUMARI SODHI |
20 |
FP2160 |
Oral eplerenone for acute central serous chorioretinopthy |
Dr. VINAY KUMAR S. |
Dr. VINAY KUMAR S. |